Innovative In Vivo Approaches to Bone Regeneration: Combining Chitosan-Xanthan Gum Membranes, Electrical Stimulation, and Laser Therapy

IF 3.8 3区 医学 Q2 ENGINEERING, BIOMEDICAL
Julia Eduarda Schneider Gregório, Renata Francielle Bombaldi de Souza, Maisa Campagnollo, Gláucia Maria Tech dos Santos, Fernanda Carla Bombaldi de Souza, Ângela Maria Moraes, Milton Santamaria-Jr, Guilherme Ferreira Caetano
{"title":"Innovative In Vivo Approaches to Bone Regeneration: Combining Chitosan-Xanthan Gum Membranes, Electrical Stimulation, and Laser Therapy","authors":"Julia Eduarda Schneider Gregório,&nbsp;Renata Francielle Bombaldi de Souza,&nbsp;Maisa Campagnollo,&nbsp;Gláucia Maria Tech dos Santos,&nbsp;Fernanda Carla Bombaldi de Souza,&nbsp;Ângela Maria Moraes,&nbsp;Milton Santamaria-Jr,&nbsp;Guilherme Ferreira Caetano","doi":"10.1002/jbm.a.70152","DOIUrl":null,"url":null,"abstract":"<p>Critical bone defects present significant clinical challenges due to their debilitating nature and associated costs. Tissue engineering offers a promising solution, employing biomaterials like porous chitosan (CH) and xanthan gum (XG) membranes as scaffolds for tissue regeneration. Electrical stimulation (ES) and laser (L) therapy, known for osteogenic and anti-inflammatory effects, respectively, may synergistically enhance bone healing when combined with these membranes. This study evaluated CH/XG membranes and their association with ES and L for the treatment of critical bone defects (25 mm<sup>2</sup>) created in 80 male Wistar rats. The animals were divided into four groups: untreated, CH/XG, CH/XG + ES, and CH/XG + L, assessed at days 30 and 90. Histomorphometric and real-time PCR analyses revealed greater tissue and blood vessel formation in the CH/XG, CH/XG + ES, and CH/XG + L groups compared to the untreated group. At day 30, reduced <i>Runx-2</i> and <i>Osx</i> expression in the treated groups suggested an initial high inflammatory response. The CH/XG group showed pronounced inflammation (elevated <i>Il-1β</i> and pro-inflammatory markers) alongside an anti-inflammatory response. Conversely, compared with the CH/XG-only group, the CH/XG + ES and CH/XG + L groups generally showed lower expression of the evaluated pro-inflammatory markers after 30 days, together with treatment- and time-dependent changes in anti-inflammatory markers. Although inflammation limited the initial effectiveness of CH/XG membranes, significant positive impacts were observed after 90 days. Combining membranes to cover bone defects and adjunctive therapies, as demonstrated in this study, emerges as a beneficial approach for enhancing bone repair outcomes. Adding osteoconductive or osteoinductive fillers may bring further healing improvements.</p>","PeriodicalId":15142,"journal":{"name":"Journal of biomedical materials research. Part A","volume":"114 9","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jbm.a.70152","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical materials research. Part A","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jbm.a.70152","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Critical bone defects present significant clinical challenges due to their debilitating nature and associated costs. Tissue engineering offers a promising solution, employing biomaterials like porous chitosan (CH) and xanthan gum (XG) membranes as scaffolds for tissue regeneration. Electrical stimulation (ES) and laser (L) therapy, known for osteogenic and anti-inflammatory effects, respectively, may synergistically enhance bone healing when combined with these membranes. This study evaluated CH/XG membranes and their association with ES and L for the treatment of critical bone defects (25 mm2) created in 80 male Wistar rats. The animals were divided into four groups: untreated, CH/XG, CH/XG + ES, and CH/XG + L, assessed at days 30 and 90. Histomorphometric and real-time PCR analyses revealed greater tissue and blood vessel formation in the CH/XG, CH/XG + ES, and CH/XG + L groups compared to the untreated group. At day 30, reduced Runx-2 and Osx expression in the treated groups suggested an initial high inflammatory response. The CH/XG group showed pronounced inflammation (elevated Il-1β and pro-inflammatory markers) alongside an anti-inflammatory response. Conversely, compared with the CH/XG-only group, the CH/XG + ES and CH/XG + L groups generally showed lower expression of the evaluated pro-inflammatory markers after 30 days, together with treatment- and time-dependent changes in anti-inflammatory markers. Although inflammation limited the initial effectiveness of CH/XG membranes, significant positive impacts were observed after 90 days. Combining membranes to cover bone defects and adjunctive therapies, as demonstrated in this study, emerges as a beneficial approach for enhancing bone repair outcomes. Adding osteoconductive or osteoinductive fillers may bring further healing improvements.

创新的体内骨再生方法:结合壳聚糖-黄原胶膜,电刺激和激光治疗。
严重的骨缺损由于其使人衰弱的性质和相关的费用,提出了重大的临床挑战。组织工程提供了一个很有前途的解决方案,使用多孔壳聚糖(CH)和黄原胶(XG)膜等生物材料作为组织再生的支架。电刺激(ES)和激光(L)治疗分别具有成骨和抗炎作用,当与这些膜结合时,可能协同促进骨愈合。本研究评估了CH/XG膜及其与ES和L治疗80只雄性Wistar大鼠(25 mm2)严重骨缺损的关系。将动物分为四组:未治疗组、CH/XG组、CH/XG + ES组和CH/XG + L组,分别在第30天和第90天进行评估。组织形态学和实时PCR分析显示,与未治疗组相比,CH/XG、CH/XG + ES和CH/XG + L组的组织和血管形成更多。在第30天,治疗组Runx-2和Osx表达减少,表明初始炎症反应高。CH/XG组表现出明显的炎症反应(Il-1β和促炎标志物升高)以及抗炎反应。相反,与仅CH/XG组相比,CH/XG + ES和CH/XG + L组在30天后普遍表现出较低的促炎标志物表达,以及治疗和时间依赖性的抗炎标志物变化。尽管炎症限制了CH/XG膜的初始有效性,但90天后观察到显著的积极影响。结合膜覆盖骨缺损和辅助治疗,正如本研究所证明的,是一种增强骨修复结果的有益方法。添加骨导电性或骨诱导性填充物可进一步改善愈合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of biomedical materials research. Part A
Journal of biomedical materials research. Part A 工程技术-材料科学:生物材料
CiteScore
10.40
自引率
2.00%
发文量
135
审稿时长
3.6 months
期刊介绍: The Journal of Biomedical Materials Research Part A is an international, interdisciplinary, English-language publication of original contributions concerning studies of the preparation, performance, and evaluation of biomaterials; the chemical, physical, toxicological, and mechanical behavior of materials in physiological environments; and the response of blood and tissues to biomaterials. The Journal publishes peer-reviewed articles on all relevant biomaterial topics including the science and technology of alloys,polymers, ceramics, and reprocessed animal and human tissues in surgery,dentistry, artificial organs, and other medical devices. The Journal also publishes articles in interdisciplinary areas such as tissue engineering and controlled release technology where biomaterials play a significant role in the performance of the medical device. The Journal of Biomedical Materials Research is the official journal of the Society for Biomaterials (USA), the Japanese Society for Biomaterials, the Australasian Society for Biomaterials, and the Korean Society for Biomaterials. Articles are welcomed from all scientists. Membership in the Society for Biomaterials is not a prerequisite for submission.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书